Wada Hideyuki, Hyun Hoon, Vargas Christina, Genega Elizabeth M, Gravier Julien, Gioux Sylvain, Frangioni John V, Choi Hak Soo
Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Ann Surg Oncol. 2015 Dec;22 Suppl 3(0 3):S1147-55. doi: 10.1245/s10434-015-4601-5. Epub 2015 May 13.
Although the sentinel lymph node (SLN) hypothesis has been applied to many tissues and organs, liver has remained unstudied. Currently, it is unclear whether hepatic SLNs even exist. If so, they could alter the management of intrahepatic cholangiocarcinoma and other hepatic malignancies by minimizing the extent of surgery while still providing precise nodal staging. This study investigated whether invisible yet tissue-penetrating near-infrared (NIR) fluorescent light can provide simultaneous identification of both the SLN and all other regional lymph nodes (RLNs) in the liver.
In 25 Yorkshire pigs, this study determined whether SLNs exist in liver and compared the effectiveness of two clinically available NIR fluorophores [methylene blue and indocyanine green (ICG)], and two novel NIR fluorophores previously described by our group (ESNF14 and ZW800-3C) for SLN and RLN mapping.
In this study, ESNF14 showed the highest signal-to-background ratio and the longest retention time in SLNs without leakage to second-tier lymph nodes. The findings showed that ICG had apparent leakage to second-tier nodes, and ZW800-3C had poor migration after intraparenchymal injection. However, when injected intravenously, ZW800-3C was able to highlight all RLNs in liver during a 4- to 6-h period. Simultaneous dual-channel imaging of SLN (ESNF14) and RLN (ZW800-3C) permitted unambiguous identification and image-guided resection of SLNs and RLNs in liver.
The NIR imaging technology enables real-time intraoperative identification of SLNs and RLNs in the liver of swine. If these results are confirmed in patients, new strategies for the surgical management of intrahepatic malignancies should be possible.
尽管前哨淋巴结(SLN)假说已应用于许多组织和器官,但肝脏尚未得到研究。目前,尚不清楚肝脏中是否存在肝前哨淋巴结。如果存在,它们可能会改变肝内胆管癌和其他肝脏恶性肿瘤的治疗方式,在缩小手术范围的同时仍能提供精确的淋巴结分期。本研究调查了不可见但能穿透组织的近红外(NIR)荧光是否能同时识别肝脏中的前哨淋巴结和所有其他区域淋巴结(RLN)。
在25只约克夏猪中,本研究确定肝脏中是否存在前哨淋巴结,并比较两种临床可用的近红外荧光团[亚甲蓝和吲哚菁绿(ICG)]以及我们团队先前描述的两种新型近红外荧光团(ESNF14和ZW800-3C)在前哨淋巴结和区域淋巴结定位中的有效性。
在本研究中,ESNF14在前哨淋巴结中显示出最高的信噪比和最长的保留时间,且不会渗漏至二级淋巴结。研究结果表明,ICG明显渗漏至二级淋巴结,而ZW800-3C在实质内注射后迁移不佳。然而,静脉注射时,ZW800-3C能够在4至6小时内突出显示肝脏中的所有区域淋巴结。前哨淋巴结(ESNF14)和区域淋巴结(ZW800-3C)的同步双通道成像允许明确识别并在图像引导下切除肝脏中的前哨淋巴结和区域淋巴结。
近红外成像技术能够在猪肝脏中实时术中识别前哨淋巴结和区域淋巴结。如果这些结果在患者中得到证实,肝内恶性肿瘤手术治疗的新策略将成为可能。